Stonepine Capital Management, LLC
Top Portfolio Positions
69 positions ·
$364,400,351 total
· as of Mar 31, 2026
| Ticker | Company | Shares | Value (USD) | % of Portfolio | Open |
|---|---|---|---|---|---|
| RADX |
Radiopharm Theranostics Ltd
Healthcare
|
51,000,000 | $219,300,000 | 60.18% | |
| VSTM |
Verastem, Inc.
Healthcare
|
3,302,300 | $17,502,190 | 4.80% | |
| ADMA |
Adma Biologics, Inc.
Healthcare
|
1,890,000 | $17,028,900 | 4.67% | |
| TENX |
Tenax Therapeutics, Inc.
Healthcare
|
975,200 | $15,593,448 | 4.28% | |
| EOLS |
Evolus, Inc.
Healthcare
|
2,179,091 | $8,956,064 | 2.46% | |
| CAMP |
Camp4 Therapeutics Corp
Healthcare
|
1,389,622 | $6,128,233 | 1.68% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
85,000 | $6,115,750 | 1.68% | |
| TERN |
Terns Pharmaceuticals, Inc.
Healthcare
|
100,000 | $5,272,000 | 1.45% | |
| ZVRA |
Zevra Therapeutics, Inc.
Healthcare
|
480,000 | $4,473,600 | 1.23% | |
| ABEO |
Abeona Therapeutics Inc.
Healthcare
|
846,587 | $3,792,709 | 1.04% |
Portfolio Trend
Holdings in AYTU
Shares Held
Position Value (USD)
11 quarters on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,162,948 | 792,289 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,115,630 | 813,704 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,676,687 | 891,855 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,771,633 | 812,676 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $556,465 | 463,721 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $692,833 | 407,549 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,177,251 | 500,958 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,379,609 | 472,469 | Shares | Sole | 2024-08-21 | |
| 2024-03-31 | $1,436,305 | 472,469 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,341,811 | 472,469 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $1,275,396 | 472,369 | Shares | Sole | 2023-11-13 | |
| No 13F history on record for this holder in this stock. | ||||||